Antirrhinum majus
Species
KNApSAcK Entry
| Organism name | Antirrhinum majus |
|---|---|
| Genus | Antirrhinum |
| Family | Plantaginaceae |
| Kingdom | Plantae |
NCBI taxonomy
Entry
| Linked NCBI taxonomy name | Antirrhinum majus |
|---|---|
| Linked NCBI taxonomy ID | 4151 |
| Linked level | species |
Family
| Family in NCBI taxonomy | Plantaginaceae |
|---|---|
| ID | 156152 |
Kingdom (Superkingdom)
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
Plant class
| Plant class | asterids |
|---|---|
| ID | 71274 |
Metabolite list (13)
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
C00004163
|
Apigenin 7,4'-diglucuronide
|
No. 1 | No. 15 |
|
||||
|
C00002376
|
Cyanidin 3-rutinoside
|
CHEMBL505251
|
C020386
|
3 / 0 / 1 | No. 1 | No. 15 |
|
|
|
C00004268
|
Luteolin 7-glucuronide
/ Luteolin 7-O-glucuronide / Luteolin 7-O-beta-D-glucuronide |
CHEMBL464224
|
C075406
|
No. 2 | No. 15 |
|
||
|
C00004339
|
Chrysoeriol 7-O-glucuronide
/ 5,7,4'-Trihydroxy-3'-methoxyflavone / Luteolin 3'-methyl ether 7-glucuronide |
CHEMBL519735
|
No. 2 | No. 15 |
|
|||
|
C00007915
|
3,4,2',4',6'-Pentahydroxychalcone 4'-glucoside
|
No. 36 | No. 13 |
|
||||
|
C00007882
|
Chalconaringenin 4'-glucoside
|
No. 36 | No. 13 |
|
||||
|
C00008046
|
Aureusin
|
No. 36 | No. 13 |
|
||||
|
C00003071
|
Antirrinoside
/ (-)-Antirrinoside |
CHEMBL364464
|
No. 64 | No. 36 |
|
|||
|
C00008027
|
Aureusidin
|
CHEMBL593229
|
No. 450 | No. 13 |
|
|||
|
C00001435
|
Tyramine
|
CHEMBL11608
|
D014439
|
23 / 11 / 6 | 6 / 9 | No. 936 | No. 6 |
|
|
C00002718
|
1-Caffeoyl-beta-D-glucose
|
CHEMBL482242
|
No. 1127 | No. 6 |
|
|||
|
C00001396
|
L-Tryptophan
|
CHEMBL54976
CHEMBL292303 CHEMBL484901 |
49 / 41 / 39 | No. 1432 | No. 4 |
|
||
|
C00001361
|
Glycine
|
CHEMBL773
|
95 / 37 / 32 | No. 3932 |
|
Human Protein / Gene in interactions
149 ChEMBL Protein in interactions
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00001361 C00001396 C00001435 | 1 / 0 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00001361 C00001396 C00001435 | 0 / 1 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00001361 C00001396 C00001435 | 0 / 1 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00001361 C00001396 C00001435 | 1 / 1 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00001361 C00001396 C00001435 | 0 / 0 |
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00001396 C00001435 | 0 / 0 |
| P21728 | D(1A) dopamine receptor | Dopamine receptor | C00001361 C00001435 | 0 / 0 |
| P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00001396 C00001435 | 2 / 0 |
| Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00001396 C00001435 | 0 / 0 |
| P46098 | 5-hydroxytryptamine receptor 3A | NS | C00001361 C00001435 | 0 / 0 |
| P21917 | D(4) dopamine receptor | Dopamine receptor | C00001361 C00001435 | 0 / 0 |
| O75496 | Geminin | Unclassified protein | C00001396 C00001435 | 0 / 0 |
| P14416 | D(2) dopamine receptor | Dopamine receptor | C00001361 C00001435 | 2 / 0 |
| Q05BR4 | SLC16A10 protein | Unclassified protein | C00001361 C00001396 | 0 / 0 |
| P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00001361 C00001435 | 1 / 1 |
| P00918 | Carbonic anhydrase 2 | Lyase | C00001361 C00001396 | 1 / 2 |
| P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00001361 | 1 / 0 |
| P29466 | Caspase-1 | C14 | C00001361 | 0 / 0 |
| P17252 | Protein kinase C alpha type | Alpha | C00001361 | 0 / 0 |
| P27361 | Mitogen-activated protein kinase 3 | Erk | C00001361 | 0 / 0 |
| P14780 | Matrix metalloproteinase-9 | M10A | C00001361 | 2 / 2 |
| Q07812 | Apoptosis regulator BAX | Unclassified protein | C00002376 | 0 / 1 |
| O15245 | Solute carrier family 22 member 1 | Drug uniporter | C00001435 | 0 / 0 |
| P02545 | Prelamin-A/C | Unclassified protein | C00001396 | 11 / 10 |
| P23415 | Glycine receptor subunit alpha-1 | GLR alpha | C00001361 | 1 / 1 |
| Q9Y263 | Phospholipase A-2-activating protein | Unclassified protein | C00001396 | 0 / 0 |
| P16473 | Thyrotropin receptor | Glycohormone receptor | C00001396 | 3 / 2 |
| P43166 | Carbonic anhydrase 7 | Lyase | C00001396 | 0 / 0 |
| P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00001361 | 0 / 1 |
| P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00001396 | 0 / 0 |
| P25021 | Histamine H2 receptor | Histamine receptor | C00001361 | 0 / 0 |
| P35367 | Histamine H1 receptor | Histamine receptor | C00001361 | 0 / 0 |
| Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00001361 | 1 / 0 |
| P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00001361 | 0 / 0 |
| P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00001361 | 0 / 0 |
| P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00001361 | 0 / 0 |
| P02768 | Serum albumin | Secreted protein | C00001396 | 0 / 0 |
| P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00001361 | 0 / 0 |
| P06241 | Tyrosine-protein kinase Fyn | Src | C00001361 | 0 / 0 |
| Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00001361 | 0 / 0 |
| Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00001396 | 0 / 0 |
| P54132 | Bloom syndrome protein | Enzyme | C00001396 | 1 / 2 |
| Q9HAW7 | UDP-glucuronosyltransferase 1-7 | Enzyme | C00001396 | 0 / 0 |
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00001361 | 1 / 8 |
| P46059 | Solute carrier family 15 member 1 | Dipeptide | C00001361 | 0 / 0 |
| P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00001361 | 0 / 0 |
| P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00001361 | 0 / 0 |
| P41145 | Kappa-type opioid receptor | Opioid receptor | C00001361 | 0 / 0 |
| Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00001361 | 0 / 0 |
| P29274 | Adenosine receptor A2a | Adenosine receptor | C00001361 | 0 / 0 |
| P23280 | Carbonic anhydrase 6 | Lyase | C00001396 | 0 / 0 |
| P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00001361 | 0 / 0 |
| P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00001361 | 1 / 1 |
| P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00001361 | 0 / 0 |
| P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00001361 | 1 / 0 |
| Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00001396 | 0 / 0 |
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00001435 | 0 / 0 |
| O43570 | Carbonic anhydrase 12 | Lyase | C00001396 | 1 / 2 |
| P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00001361 | 0 / 0 |
| Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00001396 | 0 / 0 |
| P39748 | Flap endonuclease 1 | Enzyme | C00001396 | 0 / 0 |
| Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00001396 | 0 / 0 |
| P42858 | Huntingtin | Unclassified protein | C00001396 | 1 / 1 |
| P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00001361 | 0 / 0 |
| P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00001361 | 0 / 0 |
| P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00001361 | 0 / 0 |
| Q16539 | Mitogen-activated protein kinase 14 | p38 | C00001361 | 0 / 0 |
| P30988 | Calcitonin receptor | Calcitonin receptor | C00001361 | 0 / 0 |
| P35462 | D(3) dopamine receptor | Dopamine receptor | C00001361 | 1 / 0 |
| P41143 | Delta-type opioid receptor | Opioid receptor | C00001361 | 0 / 0 |
| P33765 | Adenosine receptor A3 | Adenosine receptor | C00001361 | 0 / 0 |
| Q92731 | Estrogen receptor beta | NR3A2 | C00001361 | 0 / 1 |
| P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00001361 | 0 / 0 |
| P25101 | Endothelin-1 receptor | Endothelin receptor | C00001361 | 0 / 0 |
| P30411 | B2 bradykinin receptor | Bradykinin receptor | C00001361 | 0 / 0 |
| P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00001361 | 1 / 0 |
| P00915 | Carbonic anhydrase 1 | Lyase | C00001396 | 0 / 0 |
| P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00001361 | 0 / 0 |
| P08311 | Cathepsin G | S1A | C00001361 | 0 / 0 |
| Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00001361 | 1 / 0 |
| P03956 | Interstitial collagenase | M10A | C00001361 | 0 / 1 |
| P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00001361 | 0 / 0 |
| P09923 | Intestinal-type alkaline phosphatase | Enzyme | C00001396 | 0 / 0 |
| Q16611 | Bcl-2 homologous antagonist/killer | Unclassified protein | C00002376 | 0 / 0 |
| O43521 | Bcl-2-like protein 11 | Unclassified protein | C00002376 | 0 / 0 |
| P05186 | Alkaline phosphatase, tissue-nonspecific isozyme | Enzyme | C00001396 | 3 / 1 |
| Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00001435 | 0 / 0 |
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00001396 | 1 / 2 |
| P04150 | Glucocorticoid receptor | NR3C1 | C00001361 | 0 / 1 |
| P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00001361 | 2 / 0 |
| P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00001361 | 0 / 0 |
| P14679 | Tyrosinase | Oxidoreductase | C00001435 | 4 / 2 |
| P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00001361 | 0 / 0 |
| P31645 | Sodium-dependent serotonin transporter | Serotonin | C00001361 | 2 / 0 |
| P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00001361 | 5 / 9 |
| P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00001361 | 1 / 0 |
| P21452 | Substance-K receptor | Neurokinin receptor | C00001361 | 0 / 0 |
| P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00001361 | 0 / 0 |
| P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00001361 | 3 / 0 |
| P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00001361 | 0 / 0 |
| P36544 | Neuronal acetylcholine receptor subunit alpha-7 | CHRN alpha | C00001361 | 0 / 0 |
| P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00001361 | 1 / 0 |
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00001361 | 0 / 0 |
| P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00001361 | 2 / 1 |
| P56817 | Beta-secretase 1 | A1A | C00001435 | 0 / 0 |
| P08246 | Neutrophil elastase | S1A | C00001361 | 2 / 1 |
| Q16790 | Carbonic anhydrase 9 | Lyase | C00001396 | 0 / 1 |
| Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | C00001396 | 1 / 1 |
| Q01453 | Peripheral myelin protein 22 | Unclassified protein | C00001396 | 5 / 2 |
| O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00001361 | 0 / 0 |
| P03372 | Estrogen receptor | NR3A1 | C00001361 | 1 / 1 |
| Q16773 | Kynurenine--oxoglutarate transaminase 1 | Enzyme | C00001396 | 0 / 0 |
| P22303 | Acetylcholinesterase | Hydrolase | C00001361 | 1 / 0 |
| P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00001361 | 0 / 0 |
| P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00001361 | 0 / 0 |
| P35372 | Mu-type opioid receptor | Opioid receptor | C00001361 | 0 / 0 |
| P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00001361 | 0 / 0 |
| P25103 | Substance-P receptor | Neurokinin receptor | C00001361 | 0 / 0 |
| P25105 | Platelet-activating factor receptor | PAF receptor | C00001361 | 0 / 0 |
| P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00001361 | 0 / 0 |
| P48775 | Tryptophan 2,3-dioxygenase | Enzyme | C00001396 | 0 / 0 |
| P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00001396 | 0 / 0 |
| Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00001361 | 2 / 2 |
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00001361 | 0 / 3 |
| P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00001361 | 0 / 0 |
| Q9UNA4 | DNA polymerase iota | Enzyme | C00001396 | 0 / 0 |
| Q96RJ0 | Trace amine-associated receptor 1 | Trace amine receptor | C00001435 | 0 / 0 |
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00001396 | 0 / 0 |
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00001396 | 4 / 3 |
| Q99549 | M-phase phosphoprotein 8 | Unclassified protein | C00001396 | 0 / 0 |
| Q7Z2H8 | Proton-coupled amino acid transporter 1 | Unclassified protein | C00001361 | 0 / 0 |
| P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00001361 | 1 / 1 |
| P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00001361 | 0 / 0 |
| P30542 | Adenosine receptor A1 | Adenosine receptor | C00001361 | 0 / 0 |
| P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00001361 | 0 / 0 |
| P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00001361 | 1 / 1 |
| P07451 | Carbonic anhydrase 3 | Lyase | C00001396 | 0 / 0 |
| P06239 | Tyrosine-protein kinase Lck | Src | C00001361 | 0 / 1 |
| P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00001361 | 0 / 0 |
| P08254 | Stromelysin-1 | M10A | C00001396 | 1 / 0 |
| P22748 | Carbonic anhydrase 4 | Lyase | C00001396 | 1 / 1 |
| P27338 | Amine oxidase [flavin-containing] B | Oxidoreductase | C00001435 | 0 / 0 |
| Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | C00001396 | 0 / 0 |
| O00255 | Menin | Unclassified protein | C00001396 | 2 / 5 |
| Q13951 | Core-binding factor subunit beta | Unclassified protein | C00001396 | 0 / 1 |
| Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00001396 | 1 / 4 |
| O75751 | Solute carrier family 22 member 3 | Unclassified protein | C00001435 | 0 / 0 |
| Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00001396 | 0 / 0 |
| O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00001435 | 0 / 0 |
6 Gene in CTD interactions
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 4128 | MAOA, MAO-A | monoamine oxidase A (EC:1.4.3.4) |
C00001435
|
| 6530 | SLC6A2, NAT1, NET, NET1, SLC6A5 | solute carrier family 6 (neurotransmitter transporter), member 2 |
C00001435
|
| 6531 | SLC6A3, DAT, DAT1, PKDYS | solute carrier family 6 (neurotransmitter transporter), member 3 |
C00001435
|
| 6532 | SLC6A4, 5-HTT, 5-HTTLPR, 5HTT, HTT, OCD1, SERT, SERT1, hSERT | solute carrier family 6 (neurotransmitter transporter), member 4 |
C00001435
|
| 6818 | SULT1A3, HAST, HAST3, M-PST, ST1A3/ST1A4, ST1A5, STM, TL-PST | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 (EC:2.8.2.1) |
C00001435
|
| 134864 | TAAR1, RP11-295F4.9, TA1, TAR1, TRAR1 | trace amine associated receptor 1 |
C00001435
|
Related Diseases
Diseases related to proteins in ChEMBL interactions
OMIM (79)
| OMIM | preferred title | UniProt |
|---|---|---|
| #100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
| #103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
| #203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
| #606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
| #103780 | Alcohol dependence |
P08172
P14416 P31645 |
| #614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
| #210900 | Bloom syndrome; blm |
P54132
|
| #602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
| #300615 | Brunner syndrome |
P21397
|
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
| #118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
| #118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
| #614466 | Coronary heart disease, susceptibility to, 6; chds6 |
P08254
|
| #162800 | Cyclic neutropenia |
P08246
|
| #612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #237500 | Dubin-johnson syndrome; djs |
Q92887
|
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
| #615363 | Estrogen resistance; estrr |
P03372
|
| #600274 | Frontotemporal dementia; ftd |
P10636
|
| #613659 | Gastric cancer |
P04626
|
| #137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
| #231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
| #137800 | Glioma susceptibility 1; glm1 |
P04626
|
| #139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
| #610140 | Heart-hand syndrome, slovenian type |
P02545
|
| #609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
| #143100 | Huntington disease; hd |
P42858
|
| #176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
| #143860 | Hyperchlorhidrosis, isolated |
O43570
|
| #149400 | Hyperekplexia, hereditary 1; hkpx1 |
P23415
|
| #145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
| #603373 | Hyperthyroidism, familial gestational |
P16473
|
| #609152 | Hyperthyroidism, nonautoimmune |
P16473
|
| #145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
| #146300 | Hypophosphatasia, adult |
P05186
|
| #241510 | Hypophosphatasia, childhood |
P05186
|
| #241500 | Hypophosphatasia, infantile |
P05186
|
| #275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
| #603932 | Intervertebral disc disease; idd |
P14780
|
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
| #613688 | Long qt syndrome 2; lqt2 |
Q12809
|
| #211980 | Lung cancer |
P00533
P04626 |
| #608516 | Major depressive disorder; mdd |
P08172
|
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
| %300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
| #613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
| #131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
| #126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
| #613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
| #159900 | Myoclonic dystonia |
P14416
|
| #162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
| #202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
| #601665 | Obesity |
P32245
|
| #164230 | Obsessive-compulsive disorder; ocd |
P31645
|
| #604715 | Orthostatic intolerance |
P23975
|
| #259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
| #167000 | Ovarian cancer |
P04626
|
| #260540 | Parkinson-dementia syndrome |
P10636
|
| #613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
| #172700 | Pick disease of brain |
P10636
|
| #601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
| #607276 | Resting heart rate, variation in |
P08588
|
| #275210 | Restrictive dermopathy, lethal |
P02545
|
| #600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
| #604906 | Schizophrenia 9; sczd9 |
P49798
|
| #181500 | Schizophrenia; sczd |
P49798
|
| #608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
| #609620 | Short qt syndrome 1; sqt1 |
Q12809
|
| #601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
| #601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
| #190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
| #610379 | West nile virus, susceptibility to |
P51681
|
| #112100 | Yt blood group antigen |
P22303
|
KEGG DISEASE (69)
| KEGG | name | UniProt |
|---|---|---|
| H00033 | Adrenal carcinoma |
O00255
(related)
|
| H00034 | Carcinoid |
O00255
(related)
|
| H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
| H00246 | Primary hyperparathyroidism |
O00255
(related)
|
| H01102 | Pituitary adenomas |
O00255
(related)
|
| H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
| H00021 | Renal cell carcinoma |
O43570
(marker)
Q16790 (marker) |
| H00016 | Oral cancer |
P00533
(related)
P00533 (marker) |
| H00017 | Esophageal cancer |
P00533
(related)
P35354 (related) |
| H00018 | Gastric cancer |
P00533
(related)
P04626 (related) |
| H00022 | Bladder cancer |
P00533
(related)
P04626 (related) |
| H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) |
| H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
| H00042 | Glioma |
P00533
(related)
P00533 (marker) |
| H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
| H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
| H00436 | Osteopetrosis |
P00918
(related)
|
| H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
Q01453 (related) |
| H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
| H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
| H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
| H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
| H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
| H00663 | Restrictive dermopathy |
P02545
(related)
|
| H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
| H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
| H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) Q92731 (marker) |
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
| H00019 | Pancreatic cancer |
P04626
(related)
|
| H00027 | Ovarian cancer |
P04626
(related)
|
| H00031 | Breast cancer |
P04626
(related)
P04626 (marker) |
| H00046 | Cholangiocarcinoma |
P04626
(related)
P35354 (related) |
| H00213 | Hypophosphatasia |
P05186
(related)
|
| H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
| H00079 | Asthma |
P07550
(related)
|
| H00100 | Neutropenic disorders |
P08246
(related)
|
| H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
| H00036 | Osteosarcoma |
P08684
(marker)
|
| H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
| H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
| H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
| H00038 | Malignant melanoma |
P14679
(marker)
|
| H00025 | Penile cancer |
P14780
(related)
P35354 (related) |
| H00479 | Metaphyseal dysplasias |
P14780
(related)
|
| H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
| H01269 | Congenital hyperthyroidism |
P16473
(related)
|
| H00548 | Brunner syndrome |
P21397
(related)
|
| H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
| H00769 | Hyperekplexia |
P23415
(related)
|
| H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
| H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00059 | Huntington's disease (HD) |
P42858
(related)
|
| H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
|
| H00094 | DNA repair defects |
P54132
(related)
|
| H00296 | Defects in RecQ helicases |
P54132
(related)
|
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
| H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
| H00004 | Chronic myeloid leukemia (CML) |
Q01196
(related)
|
| H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
| H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
| H00020 | Colorectal cancer |
Q07812
(related)
|
| H00720 | Long QT syndrome |
Q12809
(related)
|
| H00725 | Short QT syndrome |
Q12809
(related)
|
| H00208 | Hyperbilirubinemia |
Q92887
(related)
|
Diseases related to CTD interactions
9 disease in interactions with metabolites
| MESH or OMIM | name |
KNApSAcK
metabolite |
|---|---|---|
| D009202 | Cardiomyopathies |
C00001435
|
| D002543 | Cerebral Hemorrhage |
C00001435
|
| D002637 | Chest Pain |
C00001435
|
| D006973 | Hypertension |
C00001435
|
| D007022 | Hypotension |
C00001435
|
| D008881 | Migraine Disorders |
C00001435
|
| D015878 | Mydriasis |
C00001435
|
| D011041 | Poisoning |
C00001435
|
| D013610 | Tachycardia |
C00001435
|